# EDGAR Filing Document

**Accession Number:** 0000019617
**File Stem:** 0000019617-23-000082
**Filing Date:** 2023-1
**Character Count:** 9787
**Document Hash:** 897248dc9eb96a4cba72cd950d084f59
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000019617-23-000082.hdr.sgml**: 20230117

**ACCESSION NUMBER**: 0000019617-23-000082

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20230117

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230117

**DATE AS OF CHANGE**: 20230117

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JPMORGAN CHASE & CO
- **CENTRAL INDEX KEY:** 0000019617
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **IRS NUMBER:** 132624428
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-05805
- **FILM NUMBER:** 23531781

**BUSINESS ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
- **BUSINESS PHONE:** 2122706000

**MAIL ADDRESS:**
- **STREET 1:** 383 MADISON AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** J P MORGAN CHASE & CO
- **DATE OF NAME CHANGE:** 20010102

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHASE MANHATTAN CORP /DE/
- **DATE OF NAME CHANGE:** 19960402

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CHEMICAL BANKING CORP
- **DATE OF NAME CHANGE:** 19920703

?xml version="1.0" ? jpm-20230117

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (date of earliest event reported): January 17, 2023** 

**JPMorgan Chase & Co.**

**(Exact name of registrant as specified in its charter)**

---

| | | | |
|:---|:---|:---|:---|
| **Delaware** | **Delaware** | **1-5805** | **13-2624428** |
| **(State or other jurisdiction of<br>incorporation or organization)** | **(State or other jurisdiction of<br>incorporation or organization)** | **(Commission File Number)** | **(I.R.S. employer<br>identification no.)** |
| **383 Madison Avenue,** | **383 Madison Avenue,** | | |
| **New York,** | **New York** | | **10179** |
| **(Address of principal executive offices)** | **(Address of principal executive offices)** | | **(Zip Code)** |

---

**Registrant's telephone number, including area code: (212) 270-6000** 

**Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:**

☐ **Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)**

☐ **Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)**

☐ **Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))**

☐ **Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))**

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading Symbol(s)</u>** | **<u>Name of each exchange on which registered</u>** |
| **Common stock** | **JPM** | **The New York Stock Exchange** |
| **Depositary Shares, each representing a one-four hundredth interest in a share of 5.75% Non-Cumulative Preferred Stock, Series DD** | **JPM PR D** | **The New York Stock Exchange** |
| **Depositary Shares, each representing a one-four hundredth interest in a share of 6.00% Non-Cumulative Preferred Stock, Series EE** | **JPM PR C** | **The New York Stock Exchange** |
| **Depositary Shares, each representing a one-four hundredth interest in a share of 4.75% Non-Cumulative Preferred Stock, Series GG** | **JPM PR J** | **The New York Stock Exchange** |
| **Depositary Shares, each representing a one-four hundredth interest in a share of 4.55% Non-Cumulative Preferred Stock, Series JJ** | **JPM PR K** | **The New York Stock Exchange** |
| **Depositary Shares, each representing a one-four hundredth interest in a share of 4.625% Non-Cumulative Preferred Stock, Series LL** | **JPM PR L** | **The New York Stock Exchange** |
| **Depositary Shares, each representing a one-four hundredth interest in a share of 4.20% Non-Cumulative Preferred Stock, Series MM** | **JPM PR M** | **The New York Stock Exchange** |
| **Alerian MLP Index ETNs due May 24, 2024** | **AMJ** | **NYSE Arca, Inc.** |
| **Guarantee of Callable Fixed Rate Notes due June 10, 2032 of JPMorgan Chase Financial Company LLC** | **JPM/32** | **The New York Stock Exchange** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

I**tem 5.02 (d) Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

JPMorgan Chase & Co. (the "Firm") elected Alicia Boler Davis as a director, effective March 20, 2023. Ms. Davis is the Chief Executive Officer of Alto Pharmacy. Ms. Davis' appointment to a board committee will be disclosed when determined. She was also elected a director of JPMorgan Chase Bank, N.A. and a manager of JPMorgan Chase Holdings LLC, and may be elected a director of such other subsidiary or subsidiaries as may be determined from time to time.

A copy of the press release announcing this election is attached hereto as Exhibit 99.1.

**Item 9.01 Financial Statements and Exhibits**

(d)&nbsp;&nbsp;&nbsp;&nbsp;Exhibit

---

| | |
|:---|:---|
| **Exhibit No.** | **Description of Exhibit** |
| 99.1 | <u>[JPMorgan Chase & Co Press Release dated January 17, 2023](jpmcpressrelease01172023.htm)</u> |
| 101 | Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language). |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101). |

---

------

<u>SIGNATURE</u>

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

JPMorgan Chase & Co. <br> (Registrant)

---

| | |
|:---|:---|
| By: | /s/ John H. Tribolati |
|  | John H. Tribolati |
|  | Corporate Secretary |

---

Dated: January 17, 2023

## Exhibit 99.1

![](jpmcpressrelease01172023001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;JPMorgan Chase & Co. 383 Madison Avenue, New York, NY 10017-2070 NYSE symbol: JPM www.jpmorganchase.com News release: IMMEDIATE RELEASE Investor Contact: Mikael Grubb Media Contact: Joseph Evangelisti 212-270-2479 212-270-7438 JPMorgan Chase Elects Alicia Boler Davis to its Board of Directors New York, January 17, 2023 – JPMorgan Chase (NYSE: JPM) announced today that Alicia Boler Davis, 53, has been elected as a director of the company, effective March 20, 2023. Ms. Davis serves as Chief Executive Officer of Alto Pharmacy. Prior to Alto, she was Senior Vice President of Global Customer Fulfillment and was a member of the Senior Team (S-Team) at Amazon. She also led Amazon's worldwide network of customer service operations, robotics and technology, as well as the company's sustainability, product assurance, real estate, construction, and procurement organizations. Prior to her roles at Amazon, she spent nearly 25 years at General Motors where she became Executive Vice President of Global Manufacturing and Labor Relations. Among other awards and accolades, in 2018 Ms. Davis was named one of The Most Powerful Female Engineers by Business Insider, Black Engineer of the Year by Career Communications Group, and in 2020 and 2021 she was named one of Fortune's Most Powerful Women. "Alicia Boler Davis has deep experience in leading complex, global businesses, and she has consistently demonstrated passion for customers and employees. Alicia will add great value to our company, and we are fortunate to attract her as a director to the firm. Along with my fellow directors and leadership team, we are looking forward to working with and learning from her," said Jamie Dimon, Chairman and CEO of JPMorgan Chase. "I am excited to join this talented and diverse board and group of leaders at JPMorgan Chase, one of the most influential companies in the world today. I look forward to bringing my expertise and experience as the firm continues to make significant investments and find innovative ways to better serve its customers, employees, and communities," said Ms. Davis. JPMorgan Chase & Co. (NYSE: JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorgan Chase had $3.7 trillion in assets and $292 billion in stockholders' equity as of December 31, 2022. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the J.P. Morgan and Chase brands, the Firm serves millions of customers in the U.S., and many of the world's most prominent corporate, institutional and government clients globally. Information about JPMorgan Chase & Co. is available at www.jpmorganchase.com. ###

------